LoginRegister
    Government to revise limit of free salicylic acid content in drugs containing ASPIRINGovernment to revise limit of free salicylic acid content in drugs containing ASPIRIN
    All medical devices sold in India to be CDSCO certified: What is MeansAll medical devices sold in India to be CDSCO certified: What is Means
    Granules India gets USFDA nod for Acetaminophen extended release tabletsGranules India gets USFDA nod for Acetaminophen extended release tablets
    Roche launches Emicizumab in India under brand name Hemlibra to treat Hemophilia ARoche launches Emicizumab in India under brand name Hemlibra to treat Hemophilia A
    Ministry of AYUSH invites initial bids for strategic sale of IMPCLMinistry of AYUSH invites initial bids for strategic sale of IMPCL
    Zydus Cadila gets final USFDA nod to generic version of Diamox for injectionZydus Cadila gets final USFDA nod to generic version of Diamox for injection
    Cipla acquires 30 percent stake in Brandmed for Rs 32 croreCipla acquires 30 percent stake in Brandmed for Rs 32 crore
    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCOAdverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO
    USFDA bans sale of Transvaginal Surgical Mesh citing safety concernsUSFDA bans sale of Transvaginal Surgical Mesh citing safety concerns
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemiaZydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia
    Cancer drugs Darzalex, Imbruvica drive JnJ to better than expected quarterly profitCancer drugs Darzalex, Imbruvica drive JnJ to better than expected quarterly profit
    Recordati to seek Canadian approval for kidney disease drug CystagonRecordati to seek Canadian approval for kidney disease drug Cystagon
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X